Sign Up Today and Learn More About Feldan Therapeutics Stock
Invest in or calculate the value of your shares in Feldan Therapeutics or other pre-IPO companies through EquityZen's platform.
Feldan Therapeutics Stock (FETH)
Feldan Therapeutics has developed a patented peptide-based technology platform.
About Feldan Therapeutics Stock
Founded
2007
Industries
Science and Engineering, Health Care, Biotechnology
Feldan Therapeutics Press Mentions
Stay in the know about the latest news on Feldan Therapeutics
Feldan Therapeutics: Investment Raised From Zynext Ventures
pulse2 • Apr 19, 2025
Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery
newswire • Apr 18, 2025
India’s Zydus invests in Feldan Therapeutics
privatecapitaljournal • Apr 17, 2025
Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery
morningstar • Apr 16, 2025
Find Therapeutics Welcomes Two New Members to Its Board of Directors
biospace • Apr 10, 2025
Feldan Therapeutics Management
Leadership team at Feldan Therapeutics
Board Member
Robert Wills
Chief Executive Officer & Co-Founder
Francois-Thomas Michaud
Join now and verify your accreditation status to gain access to:
- Feldan Therapeutics Current Valuation
- Feldan Therapeutics Stock Price
- Feldan Therapeutics Management
- Available deals in Feldan Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Feldan Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Feldan Therapeutics Revenue and Financials
- Feldan Therapeutics Highlights
- Feldan Therapeutics Business Model
- Feldan Therapeutics Risk Factors
- Feldan Therapeutics Research Report from SACRA Research
Trading Feldan Therapeutics Stock
How to invest in Feldan Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Feldan Therapeutics through EquityZen funds. These investments are made available by existing Feldan Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Feldan Therapeutics stock?
Shareholders can sell their Feldan Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
